Navigation Links
Caliper Life Sciences' Fourth Quarter and Fiscal Year 2010 Financial Results Conference Call Notice

HOPKINTON, Mass., Feb. 11, 2011 /PRNewswire/ -- Caliper Life Sciences, Inc. (Nasdaq: CALP) will conduct a conference call discussing the company's fourth quarter and fiscal year 2010 financial results at 5:00 pm Eastern (2:00 pm Pacific) on Wednesday, February 23, 2011.  Kevin Hrusovsky, President and Chief Executive Officer and Peter McAree, Chief Financial Officer, will host the call. Management will discuss operational and financial results and the company's outlook for the future.

A news release discussing Caliper's fourth quarter and fiscal year 2010 financial results will be issued on Wednesday, February 23, following the close of market.

Participants, please call 888.713.4215 five to ten minutes prior to the call and use the participant passcode of 76273346. International callers can access the call by dialing 617.213.4867 and entering the same passcode.  You may also pre-register for the call at

A live webcast of the call can be accessed at or on the Caliper website at in the Events section of the Investor Relations page. A webcast replay of the call will remain available until Caliper's earnings call for the first quarter of 2011.

Telephone replays of the conference call will be available approximately two hours after the completion of the call. To access a telephone playback of the proceedings from February 23 through March 2, dial 888-286-8010 and use the participant passcode of 91056059. International callers can access the playback by dialing 617-801-6888 and using the same participant passcode.

About Caliper Life Sciences

Caliper Life Sciences is a premier provider of cutting-edge technologies enabling researchers in the life sciences industry to create life-saving and enhancing medicines and diagnostic tests more quickly and efficiently. Caliper is aggressively innovating new technology to bridge the gap between in vitro assays and in vivo results, enabling the translation of those results into cures for human disease. Caliper's portfolio of offerings includes state-of-the-art microfluidics, lab automation & liquid handling, optical imaging technologies, and discovery & development outsourcing solutions. For more information please visit

SOURCE Caliper Life Sciences, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Caliper Life Sciences IVIS® Optical Imaging System Adoption Surpasses 1000 Units: Validated Drug Research, Discovery and Development Tool Enables Advances in Personalized Medicine
2. Caliper Life Sciences Announces Availability of Automated TruSeq™ Next Generation Sequencing Protocols
3. Caliper and Seegene Partner to Provide Innovative Multiplex Molecular Diagnostics Products
4. Caliper Life Sciences to Acquire Cambridge Research & Instrumentation
5. Caliper Continues Participation in EPAs Expanded ToxCast Program; Receives Remaining Phase II Compounds for Screening in Fourth Quarter
6. Caliper Life Sciences and Sony DADC Collaborate to Develop Plastic Microfluidic Solutions
7. Caliper Life Sciences Signs Co-Marketing Pact with Illumina to Improve Sequencing Workflows
8. Caliper Life Sciences Expands Offering for Next Generation Sequencing Workflows
9. Caliper Life Sciences Third Quarter 2010 Financial Results Conference Call Notice
10. Caliper Settles Outstanding Litigation with Shimadzu
11. Caliper Life Sciences and Stanford University File a Patent Infringement Lawsuit Against Carestream Health, Inc.
Post Your Comments:
(Date:11/26/2015)... -- Research and Markets ( ) has ... Horizons and Growth Strategies in the Italian Therapeutic ... Forecasts, Competitive Intelligence, Emerging Opportunities" report to ... --> This new 247-page report provides ... monitoring market, including emerging tests, technologies, instrumentation, sales ...
(Date:11/25/2015)... 25, 2015  Amgen (NASDAQ: AMGN ) today ... with the United States (U.S.) ... biosimilar candidate to Humira ® (adalimumab). Amgen believes ... to the FDA and represents Amgen,s first BLA submission ... Harper , M.D., executive vice president of Research and ...
(Date:11/25/2015)... MINNEAPOLIS , Nov. 25, 2015  ARKRAY ... care products, continues to provide evidence demonstrating the accuracy ... the World Congress on Insulin Resistance, Diabetes and Cardiovascular ... showed that both the Company,s GLUCOCARD ® 01 ... met high accuracy requirements. The ability to accurately measure ...
Breaking Medicine Technology:
(Date:11/25/2015)... ... November 25, 2015 , ... Wimbledon Health ... launches new Wimbledon Athletics Facebook page to educate the public, parents ... cardiac abnormalities. About 2,000 people under the age of 25 die from sudden ...
(Date:11/25/2015)... (PRWEB) , ... November 25, 2015 , ... On November ... of Tri Lite’s personal heating products business. Cozy Products explains what this ... heaters that fit in well with the Cozy Products business model: to sell personal ...
(Date:11/25/2015)... ... ... SCOTTSDALE, AZ) - Today, Dr. Todd C. Hobgood ... non-surgical treatments, announced the expansion of his private practice capabilities with the grand ... trained and nationally recognized for his natural approach, Dr. Todd Hobgood serves the ...
(Date:11/25/2015)... ... November 25, 2015 , ... Brillianteen, McGaw YMCA’s ... learning in its 65th Anniversary Brillianteen Revue, scheduled for March 4-6, 2016. Auditions ... 65 years, Brillianteen has been a treasured tradition for numerous families in the ...
(Date:11/25/2015)... ... November 25, 2015 , ... “While riding the bus, I saw a passenger ... thought there had to be a convenient and comfortable way to protect them from ... disabled individuals to safely travel during cold or inclement weather. In doing so, it ...
Breaking Medicine News(10 mins):